Nathan Cheng (@realNathanCheng), program director for On Deck Longevity, joins Erik on this episode to discuss:
- The key breakthroughs in aging research in the past.
- Why we're still waiting for the first success story in humans, and why he predicts the first drug will be approved in the next ten years.
- Why the space has plenty of capital but not enough founders.
- The challenges and roadblocks in the space.
- Common misconceptions about longevity.
- Who should think about applying to the program.
Thanks for listening — if you like what you hear, please review us on your favorite podcast platform.
Check us out on the web at
www.villageglobal.vc or get in touch with us on Twitter @villageglobal.
Want to get updates from us? Subscribe to get a peek inside the Village. We’ll send you reading recommendations, exclusive event invites, and commentary on the latest happenings in Silicon Valley.
www.villageglobal.vc/signup
